GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2129.9064.5 (+3.12 %)
PREV CLOSE ( ) 2065.40
OPEN PRICE ( ) 2070.10
BID PRICE (QTY) 2127.15 (1)
OFFER PRICE (QTY) 2129.90 (1)
VOLUME 6052
TODAY'S LOW / HIGH ( )2056.60 2145.75
52 WK LOW / HIGH ( )1228 2649.95
NSE2135.0069.4 (+3.36 %)
PREV CLOSE( ) 2065.60
OPEN PRICE ( ) 2073.90
BID PRICE (QTY) 2135.00 (152)
OFFER PRICE (QTY) 2135.05 (79)
VOLUME 225031
TODAY'S LOW / HIGH( ) 2053.00 2148.00
52 WK LOW / HIGH ( )1227 2524
Exchange
Year Open Price () High Price () Low Price () Close Price () Volume (000's) Value (lakhs)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.